KP
DXCM icon

Keel Point’s DexCom DXCM Stock Holding History

Keel Point’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,473
Closed -$430K – 501
2025
Q4 		$430K Buy
6,473
+193
+3% +$12.5K 0.03% 331
2025
Q3 		$423K Buy
6,280
+2,528
+67% +$200K 0.03% 337
2025
Q2 		$328K Buy
+3,752
New +$294K 0.02% 382
2024
Q2 		– Sell
-1,683
Closed -$233K – 447
2024
Q1 		$233K Hold
1,683
– – 0.02% 336
2023
Q4 		$209K Buy
+1,683
New +$172K 0.02% 327

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Keel Point's DXCM Position: Q1 2026 in Review

Keel Point sold out of DexCom (DXCM) in Q1 2026, closing a stake of 6,473 shares — an estimated $430K sold.

Keel Point first reported a position in DXCM in Q4 2023 and held it in 5 quarters. The position peaked at $430K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Keel Point reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Keel Point sold 6,473 DexCom shares in Q1 2026, an estimated $430K.
  • Keel Point first reported a position in DexCom in Q4 2023 and held it in 5 quarters.
  • Keel Point's DexCom position peaked at $430K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.